Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member] Common Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balances (in shares) at Dec. 31, 2022						19,681,644
Balances (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022	$ 0	$ 0	$ 1,080		$ 1,080
Balances at Dec. 31, 2022						$ 24,602	$ 77,502	$ 64,873	$ (48,028)	$ 118,949
Net income for the period						0	0	2,663	0	2,663
Cash dividends						0	0	(1,771)	0	(1,771)
Restricted stock awards						$ 0	121	0	0	$ 121
Common shares issued through dividend reinvestment/optional cash purchase plan (in shares)						2,229				2,229
Common shares issued through dividend reinvestment/optional cash purchase plan						$ 2	13	(11)	0	$ 4
Other comprehensive income						$ 0	0	0	5,448	5,448
Balances (in shares) at Mar. 31, 2023						19,683,873
Balances at Mar. 31, 2023						$ 24,604	77,636	66,834	(42,580)	126,494
Balances (in shares) at Dec. 31, 2023						19,787,031
Balances at Dec. 31, 2023						$ 24,733	78,253	71,782	(40,169)	134,599
Net income for the period						0	0	3,532	0	3,532
Cash dividends						0	0	(1,782)	0	(1,782)
Restricted stock awards						$ 0	143	0	0	$ 143
Common shares issued through dividend reinvestment/optional cash purchase plan (in shares)						1,254				1,254
Common shares issued through dividend reinvestment/optional cash purchase plan						$ 1	6	(10)	0	$ (3)
Other comprehensive income						$ 0	0	0	1,237	1,237
Common shares issued in consideration of an asset purchase (in shares)						2,375
Common shares issued in consideration of an asset purchase						$ 3	16	0	0	19
Common shares issued under long-term incentive compensation plan (in shares)						4,491
Common shares issued under long-term incentive compensation plan						$ 6	(6)	0	0	0
Balances (in shares) at Mar. 31, 2024						19,795,151
Balances at Mar. 31, 2024						$ 24,743	$ 78,412	$ 73,522	$ (38,932)	$ 137,745